
### [MONDO:0015123](http://purl.obolibrary.org/obo/MONDO_0015123)
**Label:** rare dyslipidemia

**Subclasses:** [MONDO:0016203](http://purl.obolibrary.org/obo/MONDO_0016203) (hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency), [MONDO:0011393](http://purl.obolibrary.org/obo/MONDO_0011393) (apolipoprotein A-I deficiency), [MONDO:0011470](http://purl.obolibrary.org/obo/MONDO_0011470) (hyperlipidemia, combined, 2), [MONDO:0017973](http://purl.obolibrary.org/obo/MONDO_0017973) (non-classic congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0017972](http://purl.obolibrary.org/obo/MONDO_0017972) (classic congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0017774](http://purl.obolibrary.org/obo/MONDO_0017774) (hypobetalipoproteinemia), [MONDO:0019597](http://purl.obolibrary.org/obo/MONDO_0019597) (46,XY disorder of sex development due to isolated 17,20-lyase deficiency), [MONDO:0017773](http://purl.obolibrary.org/obo/MONDO_0017773) (hypoalphalipoproteinemia), [MONDO:0008783](http://purl.obolibrary.org/obo/MONDO_0008783) (Tangier disease), [MONDO:0008863](http://purl.obolibrary.org/obo/MONDO_0008863) (sitosterolemia), [MONDO:0009515](http://purl.obolibrary.org/obo/MONDO_0009515) (Norum disease), [MONDO:0007327](http://purl.obolibrary.org/obo/MONDO_0007327) (chylomicronemia, familial, due to circulating inhibitor of lipoprotein lipase), [MONDO:0008948](http://purl.obolibrary.org/obo/MONDO_0008948) (cerebrotendinous xanthomatosis), [MONDO:0007762](http://purl.obolibrary.org/obo/MONDO_0007762) (hyperlipoproteinemia type V), [MONDO:0010543](http://purl.obolibrary.org/obo/MONDO_0010543) (Barth syndrome), [MONDO:0011237](http://purl.obolibrary.org/obo/MONDO_0011237) (hyperlipidemia, combined, 1), [MONDO:0013533](http://purl.obolibrary.org/obo/MONDO_0013533) (hyperlipidemia due to hepatic triglyceride lipase deficiency), [MONDO:0012725](http://purl.obolibrary.org/obo/MONDO_0012725) (lipoprotein glomerulopathy), [MONDO:0013534](http://purl.obolibrary.org/obo/MONDO_0013534) (apolipoprotein c-Iii deficiency), [MONDO:0014789](http://purl.obolibrary.org/obo/MONDO_0014789) (CCDC115-CDG), [MONDO:0015515](http://purl.obolibrary.org/obo/MONDO_0015515) (carnitine palmitoyltransferase II deficiency), [MONDO:0014412](http://purl.obolibrary.org/obo/MONDO_0014412) (hyperlipoproteinemia, type 1D), [MONDO:0008692](http://purl.obolibrary.org/obo/MONDO_0008692) (abetalipoproteinemia), [MONDO:0019148](http://purl.obolibrary.org/obo/MONDO_0019148) (Wolman disease), [MONDO:0014252](http://purl.obolibrary.org/obo/MONDO_0014252) (familial hypobetalipoproteinemia 1), [MONDO:0019149](http://purl.obolibrary.org/obo/MONDO_0019149) (cholesteryl ester storage disease), [MONDO:0009387](http://purl.obolibrary.org/obo/MONDO_0009387) (familial lipoprotein lipase deficiency), [MONDO:0017840](http://purl.obolibrary.org/obo/MONDO_0017840) (classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form), [MONDO:0013681](http://purl.obolibrary.org/obo/MONDO_0013681) (alpha-methylacyl-CoA racemase deficiency), [MONDO:0008730](http://purl.obolibrary.org/obo/MONDO_0008730) (congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency), [MONDO:0008810](http://purl.obolibrary.org/obo/MONDO_0008810) (familial apolipoprotein C-II deficiency), [MONDO:0009704](http://purl.obolibrary.org/obo/MONDO_0009704) (carnitine palmitoyl transferase II deficiency, myopathic form), [MONDO:0009705](http://purl.obolibrary.org/obo/MONDO_0009705) (carnitine palmitoyltransferase i deficiency), [MONDO:0011906](http://purl.obolibrary.org/obo/MONDO_0011906) (congenital bile acid synthesis defect 1), [MONDO:0015903](http://purl.obolibrary.org/obo/MONDO_0015903) (hyperalphalipoproteinemia), [MONDO:0015308](http://purl.obolibrary.org/obo/MONDO_0015308) (laminopathy type Decaudain-Vigouroux), [MONDO:0015902](http://purl.obolibrary.org/obo/MONDO_0015902) (major hypertriglyceridemia), [MONDO:0015905](http://purl.obolibrary.org/obo/MONDO_0015905) (rare syndromic dyslipidemia), [MONDO:0015904](http://purl.obolibrary.org/obo/MONDO_0015904) (rare hypolipidemia), [MONDO:0011505](http://purl.obolibrary.org/obo/MONDO_0011505) (familial hypobetalipoproteinemia 2), [MONDO:0015901](http://purl.obolibrary.org/obo/MONDO_0015901) (rare hyperlipidemia), [MONDO:0015015](http://purl.obolibrary.org/obo/MONDO_0015015) (congenital bile acid synthesis defect 6), [MONDO:0013310](http://purl.obolibrary.org/obo/MONDO_0013310) (congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency), [MONDO:0018328](http://purl.obolibrary.org/obo/MONDO_0018328) (homozygous familial hypercholesterolemia), [MONDO:0014564](http://purl.obolibrary.org/obo/MONDO_0014564) (congenital bile acid synthesis defect 5), [MONDO:0018841](http://purl.obolibrary.org/obo/MONDO_0018841) (congenital bile acid synthesis defect), [MONDO:0011374](http://purl.obolibrary.org/obo/MONDO_0011374) (autosomal recessive hypercholesterolemia), [MONDO:0009530](http://purl.obolibrary.org/obo/MONDO_0009530) (lipoid proteinosis), [MONDO:0001807](http://purl.obolibrary.org/obo/MONDO_0001807) (familial combined hyperlipidemia), [MONDO:0009339](http://purl.obolibrary.org/obo/MONDO_0009339) (congenital bile acid synthesis defect 2), [MONDO:0008967](http://purl.obolibrary.org/obo/MONDO_0008967) (congenital bile acid synthesis defect 4), [MONDO:0008725](http://purl.obolibrary.org/obo/MONDO_0008725) (congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0008727](http://purl.obolibrary.org/obo/MONDO_0008727) (congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency), [MONDO:0007744](http://purl.obolibrary.org/obo/MONDO_0007744) (cholesterol-ester transfer protein deficiency), [MONDO:0007788](http://purl.obolibrary.org/obo/MONDO_0007788) (hypertriglyceridemia, familial), [MONDO:0008728](http://purl.obolibrary.org/obo/MONDO_0008728) (classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency), [MONDO:0008729](http://purl.obolibrary.org/obo/MONDO_0008729) (congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency), [MONDO:0007620](http://purl.obolibrary.org/obo/MONDO_0007620) (fish-eye disease), [MONDO:0017839](http://purl.obolibrary.org/obo/MONDO_0017839) (classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form), [MONDO:0013439](http://purl.obolibrary.org/obo/MONDO_0013439) (congenital bile acid synthesis defect 3), [MONDO:0010204](http://purl.obolibrary.org/obo/MONDO_0010204) (lysosomal acid lipase deficiency), [MONDO:0018999](http://purl.obolibrary.org/obo/MONDO_0018999) (LCAT deficiency), [MONDO:0018479](http://purl.obolibrary.org/obo/MONDO_0018479) (congenital adrenal hyperplasia), [MONDO:0018799](http://purl.obolibrary.org/obo/MONDO_0018799) (rare hypercholesterolemia), [MONDO:0013664](http://purl.obolibrary.org/obo/MONDO_0013664) (46,XY disorder of sex development due to testicular 17,20-desmolase deficiency), [MONDO:0014790](http://purl.obolibrary.org/obo/MONDO_0014790) (TMEM199-CDG), [MONDO:0018473](http://purl.obolibrary.org/obo/MONDO_0018473) (hyperlipoproteinemia type 3), [MONDO:0007759](http://purl.obolibrary.org/obo/MONDO_0007759) (hyperlipidemia, familial combined, LPL related), [MONDO:0009528](http://purl.obolibrary.org/obo/MONDO_0009528) (chylomicron retention disease), [MONDO:0010914](http://purl.obolibrary.org/obo/MONDO_0010914) (carnitine palmitoyl transferase II deficiency, severe infantile form), [MONDO:0010035](http://purl.obolibrary.org/obo/MONDO_0010035) (Smith-Lemli-Opitz syndrome), [MONDO:0012136](http://purl.obolibrary.org/obo/MONDO_0012136) (carnitine palmitoyl transferase II deficiency, neonatal form), [MONDO:0011207](http://purl.obolibrary.org/obo/MONDO_0011207) (xanthomatosis, susceptibility to), [MONDO:0018637](http://purl.obolibrary.org/obo/MONDO_0018637) (familial chylomicronemia syndrome), 

**Mapped go classes:** [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0019915](http://purl.obolibrary.org/obo/GO_0019915) (lipid storage), [GO:0034197](http://purl.obolibrary.org/obo/GO_0034197) (triglyceride transport), [GO:0005874](http://purl.obolibrary.org/obo/GO_0005874) (microtubule), [GO:0050796](http://purl.obolibrary.org/obo/GO_0050796) (regulation of insulin secretion), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0005504](http://purl.obolibrary.org/obo/GO_0005504) (fatty acid binding), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0000060](http://purl.obolibrary.org/obo/GO_0000060) (protein import into nucleus, translocation), [GO:2000353](http://purl.obolibrary.org/obo/GO_2000353) (positive regulation of endothelial cell apoptotic process), [GO:0071379](http://purl.obolibrary.org/obo/GO_0071379) (cellular response to prostaglandin stimulus), [GO:0050679](http://purl.obolibrary.org/obo/GO_0050679) (positive regulation of epithelial cell proliferation), [GO:0016655](http://purl.obolibrary.org/obo/GO_0016655) (oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor), [GO:0034185](http://purl.obolibrary.org/obo/GO_0034185) (apolipoprotein binding), [GO:0034186](http://purl.obolibrary.org/obo/GO_0034186) (apolipoprotein A-I binding), [GO:0060230](http://purl.obolibrary.org/obo/GO_0060230) (lipoprotein lipase activator activity), [GO:0005640](http://purl.obolibrary.org/obo/GO_0005640) (nuclear outer membrane), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0004303](http://purl.obolibrary.org/obo/GO_0004303) (estradiol 17-beta-dehydrogenase activity), [GO:0005758](http://purl.obolibrary.org/obo/GO_0005758) (mitochondrial intermembrane space), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0072574](http://purl.obolibrary.org/obo/GO_0072574) (hepatocyte proliferation), [GO:0047045](http://purl.obolibrary.org/obo/GO_0047045) (testosterone 17-beta-dehydrogenase (NADP+) activity), [GO:0051897](http://purl.obolibrary.org/obo/GO_0051897) (positive regulation of protein kinase B signaling), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0035265](http://purl.obolibrary.org/obo/GO_0035265) (organ growth), [GO:0016746](http://purl.obolibrary.org/obo/GO_0016746) (transferase activity, transferring acyl groups), [GO:0016627](http://purl.obolibrary.org/obo/GO_0016627) (oxidoreductase activity, acting on the CH-CH group of donors), [GO:0016628](http://purl.obolibrary.org/obo/GO_0016628) (oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0006700](http://purl.obolibrary.org/obo/GO_0006700) (C21-steroid hormone biosynthetic process), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0042953](http://purl.obolibrary.org/obo/GO_0042953) (lipoprotein transport), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0071395](http://purl.obolibrary.org/obo/GO_0071395) (cellular response to jasmonic acid stimulus), [GO:0048385](http://purl.obolibrary.org/obo/GO_0048385) (regulation of retinoic acid receptor signaling pathway), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0071277](http://purl.obolibrary.org/obo/GO_0071277) (cellular response to calcium ion), [GO:0006936](http://purl.obolibrary.org/obo/GO_0006936) (muscle contraction), [GO:0048025](http://purl.obolibrary.org/obo/GO_0048025) (negative regulation of mRNA splicing, via spliceosome), [GO:0071276](http://purl.obolibrary.org/obo/GO_0071276) (cellular response to cadmium ion), [GO:0048261](http://purl.obolibrary.org/obo/GO_0048261) (negative regulation of receptor-mediated endocytosis), [GO:2000379](http://purl.obolibrary.org/obo/GO_2000379) (positive regulation of reactive oxygen species metabolic process), [GO:0016616](http://purl.obolibrary.org/obo/GO_0016616) (oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor), [GO:0004771](http://purl.obolibrary.org/obo/GO_0004771) (sterol esterase activity), [GO:0005741](http://purl.obolibrary.org/obo/GO_0005741) (mitochondrial outer membrane), [GO:0005740](http://purl.obolibrary.org/obo/GO_0005740) (mitochondrial envelope), [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0042843](http://purl.obolibrary.org/obo/GO_0042843) (D-xylose catabolic process), [GO:0006703](http://purl.obolibrary.org/obo/GO_0006703) (estrogen biosynthetic process), [GO:0006704](http://purl.obolibrary.org/obo/GO_0006704) (glucocorticoid biosynthetic process), [GO:0071384](http://purl.obolibrary.org/obo/GO_0071384) (cellular response to corticosteroid stimulus), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0047184](http://purl.obolibrary.org/obo/GO_0047184) (1-acylglycerophosphocholine O-acyltransferase activity), [GO:0006707](http://purl.obolibrary.org/obo/GO_0006707) (cholesterol catabolic process), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0004769](http://purl.obolibrary.org/obo/GO_0004769) (steroid delta-isomerase activity), [GO:0006705](http://purl.obolibrary.org/obo/GO_0006705) (mineralocorticoid biosynthetic process), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0006709](http://purl.obolibrary.org/obo/GO_0006709) (progesterone catabolic process), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0106003](http://purl.obolibrary.org/obo/GO_0106003) (amyloid-beta complex), [GO:0055096](http://purl.obolibrary.org/obo/GO_0055096) (low-density lipoprotein particle mediated signaling), [GO:0036295](http://purl.obolibrary.org/obo/GO_0036295) (cellular response to increased oxygen levels), [GO:1900210](http://purl.obolibrary.org/obo/GO_1900210) (positive regulation of cardiolipin metabolic process), [GO:0002040](http://purl.obolibrary.org/obo/GO_0002040) (sprouting angiogenesis), [GO:0006641](http://purl.obolibrary.org/obo/GO_0006641) (triglyceride metabolic process), [GO:0005791](http://purl.obolibrary.org/obo/GO_0005791) (rough endoplasmic reticulum), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0005793](http://purl.obolibrary.org/obo/GO_0005793) (endoplasmic reticulum-Golgi intermediate compartment), [GO:0006644](http://purl.obolibrary.org/obo/GO_0006644) (phospholipid metabolic process), [GO:0006886](http://purl.obolibrary.org/obo/GO_0006886) (intracellular protein transport), [GO:0004465](http://purl.obolibrary.org/obo/GO_0004465) (lipoprotein lipase activity), [GO:0055090](http://purl.obolibrary.org/obo/GO_0055090) (acylglycerol homeostasis), [GO:0007613](http://purl.obolibrary.org/obo/GO_0007613) (memory), [GO:0006642](http://purl.obolibrary.org/obo/GO_0006642) (triglyceride mobilization), [GO:0055091](http://purl.obolibrary.org/obo/GO_0055091) (phospholipid homeostasis), [GO:0008941](http://purl.obolibrary.org/obo/GO_0008941) (nitric oxide dioxygenase activity), [GO:0006879](http://purl.obolibrary.org/obo/GO_0006879) (cellular iron ion homeostasis), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0030502](http://purl.obolibrary.org/obo/GO_0030502) (negative regulation of bone mineralization), [GO:0006635](http://purl.obolibrary.org/obo/GO_0006635) (fatty acid beta-oxidation), [GO:0050750](http://purl.obolibrary.org/obo/GO_0050750) (low-density lipoprotein particle receptor binding), [GO:0005548](http://purl.obolibrary.org/obo/GO_0005548) (phospholipid transporter activity), [GO:0045056](http://purl.obolibrary.org/obo/GO_0045056) (transcytosis), [GO:0047598](http://purl.obolibrary.org/obo/GO_0047598) (7-dehydrocholesterol reductase activity), [GO:0071333](http://purl.obolibrary.org/obo/GO_0071333) (cellular response to glucose stimulus), [GO:0050996](http://purl.obolibrary.org/obo/GO_0050996) (positive regulation of lipid catabolic process), [GO:0030500](http://purl.obolibrary.org/obo/GO_0030500) (regulation of bone mineralization), [GO:0015485](http://purl.obolibrary.org/obo/GO_0015485) (cholesterol binding), [GO:1900221](http://purl.obolibrary.org/obo/GO_1900221) (regulation of amyloid-beta clearance), [GO:1902884](http://purl.obolibrary.org/obo/GO_1902884) (positive regulation of response to oxidative stress), [GO:0007623](http://purl.obolibrary.org/obo/GO_0007623) (circadian rhythm), [GO:0006656](http://purl.obolibrary.org/obo/GO_0006656) (phosphatidylcholine biosynthetic process), [GO:0005324](http://purl.obolibrary.org/obo/GO_0005324) (long-chain fatty acid transporter activity), [GO:0071560](http://purl.obolibrary.org/obo/GO_0071560) (cellular response to transforming growth factor beta stimulus), [GO:0005319](http://purl.obolibrary.org/obo/GO_0005319) (lipid transporter activity), [GO:0009918](http://purl.obolibrary.org/obo/GO_0009918) (sterol delta7 reductase activity), [GO:0010902](http://purl.obolibrary.org/obo/GO_0010902) (positive regulation of very-low-density lipoprotein particle remodeling), [GO:0050769](http://purl.obolibrary.org/obo/GO_0050769) (positive regulation of neurogenesis), [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:0016567](http://purl.obolibrary.org/obo/GO_0016567) (protein ubiquitination), [GO:0016788](http://purl.obolibrary.org/obo/GO_0016788) (hydrolase activity, acting on ester bonds), [GO:0060228](http://purl.obolibrary.org/obo/GO_0060228) (phosphatidylcholine-sterol O-acyltransferase activator activity), [GO:0005770](http://purl.obolibrary.org/obo/GO_0005770) (late endosome), [GO:0090197](http://purl.obolibrary.org/obo/GO_0090197) (positive regulation of chemokine secretion), [GO:0060229](http://purl.obolibrary.org/obo/GO_0060229) (lipase activator activity), [GO:0047006](http://purl.obolibrary.org/obo/GO_0047006) (17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0047372](http://purl.obolibrary.org/obo/GO_0047372) (acylglycerol lipase activity), [GO:0005769](http://purl.obolibrary.org/obo/GO_0005769) (early endosome), [GO:0002017](http://purl.obolibrary.org/obo/GO_0002017) (regulation of blood volume by renal aldosterone), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0071470](http://purl.obolibrary.org/obo/GO_0071470) (cellular response to osmotic stress), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0047016](http://purl.obolibrary.org/obo/GO_0047016) (cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity), [GO:0005782](http://purl.obolibrary.org/obo/GO_0005782) (peroxisomal matrix), [GO:0005543](http://purl.obolibrary.org/obo/GO_0005543) (phospholipid binding), [GO:0006633](http://purl.obolibrary.org/obo/GO_0006633) (fatty acid biosynthetic process), [GO:0060697](http://purl.obolibrary.org/obo/GO_0060697) (positive regulation of phospholipid catabolic process), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0005778](http://purl.obolibrary.org/obo/GO_0005778) (peroxisomal membrane), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0005777](http://purl.obolibrary.org/obo/GO_0005777) (peroxisome), [GO:0050661](http://purl.obolibrary.org/obo/GO_0050661) (NADP binding), [GO:0047020](http://purl.obolibrary.org/obo/GO_0047020) (15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity), [GO:0050660](http://purl.obolibrary.org/obo/GO_0050660) (flavin adenine dinucleotide binding), [GO:0048598](http://purl.obolibrary.org/obo/GO_0048598) (embryonic morphogenesis), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0047023](http://purl.obolibrary.org/obo/GO_0047023) (androsterone dehydrogenase activity), [GO:0071466](http://purl.obolibrary.org/obo/GO_0071466) (cellular response to xenobiotic stimulus), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0043627](http://purl.obolibrary.org/obo/GO_0043627) (response to estrogen), [GO:2001171](http://purl.obolibrary.org/obo/GO_2001171) (positive regulation of ATP biosynthetic process), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0097250](http://purl.obolibrary.org/obo/GO_0097250) (mitochondrial respiratory chain supercomplex assembly), [GO:0042775](http://purl.obolibrary.org/obo/GO_0042775) (mitochondrial ATP synthesis coupled electron transport), [GO:0043621](http://purl.obolibrary.org/obo/GO_0043621) (protein self-association), [GO:0051005](http://purl.obolibrary.org/obo/GO_0051005) (negative regulation of lipoprotein lipase activity), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0051000](http://purl.obolibrary.org/obo/GO_0051000) (positive regulation of nitric-oxide synthase activity), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0097006](http://purl.obolibrary.org/obo/GO_0097006) (regulation of plasma lipoprotein particle levels), [GO:0016132](http://purl.obolibrary.org/obo/GO_0016132) (brassinosteroid biosynthetic process), [GO:0030301](http://purl.obolibrary.org/obo/GO_0030301) (cholesterol transport), [GO:0030300](http://purl.obolibrary.org/obo/GO_0030300) (regulation of intestinal cholesterol absorption), [GO:0030663](http://purl.obolibrary.org/obo/GO_0030663) (COPI-coated vesicle membrane), [GO:0051006](http://purl.obolibrary.org/obo/GO_0051006) (positive regulation of lipoprotein lipase activity), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0000902](http://purl.obolibrary.org/obo/GO_0000902) (cell morphogenesis), [GO:0006695](http://purl.obolibrary.org/obo/GO_0006695) (cholesterol biosynthetic process), [GO:0051260](http://purl.obolibrary.org/obo/GO_0051260) (protein homooligomerization), [GO:0004032](http://purl.obolibrary.org/obo/GO_0004032) (alditol:NADP+ 1-oxidoreductase activity), [GO:0006696](http://purl.obolibrary.org/obo/GO_0006696) (ergosterol biosynthetic process), [GO:0006694](http://purl.obolibrary.org/obo/GO_0006694) (steroid biosynthetic process), [GO:0004033](http://purl.obolibrary.org/obo/GO_0004033) (aldo-keto reductase (NADP) activity), [GO:0006699](http://purl.obolibrary.org/obo/GO_0006699) (bile acid biosynthetic process), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle), [GO:0010942](http://purl.obolibrary.org/obo/GO_0010942) (positive regulation of cell death), [GO:0016004](http://purl.obolibrary.org/obo/GO_0016004) (phospholipase activator activity), [GO:0016125](http://purl.obolibrary.org/obo/GO_0016125) (sterol metabolic process), [GO:0016488](http://purl.obolibrary.org/obo/GO_0016488) (farnesol catabolic process), [GO:0051259](http://purl.obolibrary.org/obo/GO_0051259) (protein oligomerization), [GO:0031983](http://purl.obolibrary.org/obo/GO_0031983) (vesicle lumen), [GO:0016126](http://purl.obolibrary.org/obo/GO_0016126) (sterol biosynthetic process), [GO:0016229](http://purl.obolibrary.org/obo/GO_0016229) (steroid dehydrogenase activity), [GO:0015012](http://purl.obolibrary.org/obo/GO_0015012) (heparan sulfate proteoglycan biosynthetic process), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0045823](http://purl.obolibrary.org/obo/GO_0045823) (positive regulation of heart contraction), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0045703](http://purl.obolibrary.org/obo/GO_0045703) (ketoreductase activity), [GO:0005215](http://purl.obolibrary.org/obo/GO_0005215) (transporter activity), [GO:0005578](http://purl.obolibrary.org/obo/GO_0005578) (proteinaceous extracellular matrix), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0010916](http://purl.obolibrary.org/obo/GO_0010916) (negative regulation of very-low-density lipoprotein particle clearance), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0006658](http://purl.obolibrary.org/obo/GO_0006658) (phosphatidylserine metabolic process), [GO:0051384](http://purl.obolibrary.org/obo/GO_0051384) (response to glucocorticoid), [GO:0016471](http://purl.obolibrary.org/obo/GO_0016471) (vacuolar proton-transporting V-type ATPase complex), [GO:0042448](http://purl.obolibrary.org/obo/GO_0042448) (progesterone metabolic process), [GO:0018636](http://purl.obolibrary.org/obo/GO_0018636) (phenanthrene 9,10-monooxygenase activity), [GO:0008970](http://purl.obolibrary.org/obo/GO_0008970) (phosphatidylcholine 1-acylhydrolase activity), [GO:0045834](http://purl.obolibrary.org/obo/GO_0045834) (positive regulation of lipid metabolic process), [GO:0004497](http://purl.obolibrary.org/obo/GO_0004497) (monooxygenase activity), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:1990042](http://purl.obolibrary.org/obo/GO_1990042) (glycerol dehydrogenase [NAD(P)+] activity), [GO:0042446](http://purl.obolibrary.org/obo/GO_0042446) (hormone biosynthetic process), [GO:0045833](http://purl.obolibrary.org/obo/GO_0045833) (negative regulation of lipid metabolic process), [GO:0004128](http://purl.obolibrary.org/obo/GO_0004128) (cytochrome-b5 reductase activity, acting on NAD(P)H), [GO:0030516](http://purl.obolibrary.org/obo/GO_0030516) (regulation of axon extension), [GO:0031966](http://purl.obolibrary.org/obo/GO_0031966) (mitochondrial membrane), [GO:0007519](http://purl.obolibrary.org/obo/GO_0007519) (skeletal muscle tissue development), [GO:0016589](http://purl.obolibrary.org/obo/GO_0016589) (NURF complex), [GO:0032770](http://purl.obolibrary.org/obo/GO_0032770) (positive regulation of monooxygenase activity), [GO:1900053](http://purl.obolibrary.org/obo/GO_1900053) (negative regulation of retinoic acid biosynthetic process), [GO:0060048](http://purl.obolibrary.org/obo/GO_0060048) (cardiac muscle contraction), [GO:0006006](http://purl.obolibrary.org/obo/GO_0006006) (glucose metabolic process), [GO:1903449](http://purl.obolibrary.org/obo/GO_1903449) (androst-4-ene-3,17-dione biosynthetic process), [GO:0016050](http://purl.obolibrary.org/obo/GO_0016050) (vesicle organization), [GO:0048168](http://purl.obolibrary.org/obo/GO_0048168) (regulation of neuronal synaptic plasticity), [GO:0030343](http://purl.obolibrary.org/obo/GO_0030343) (vitamin D3 25-hydroxylase activity), [GO:0016298](http://purl.obolibrary.org/obo/GO_0016298) (lipase activity), [GO:0019568](http://purl.obolibrary.org/obo/GO_0019568) (arabinose catabolic process), [GO:0017129](http://purl.obolibrary.org/obo/GO_0017129) (triglyceride binding), [GO:0042626](http://purl.obolibrary.org/obo/GO_0042626) (ATPase activity, coupled to transmembrane movement of substances), [GO:0042627](http://purl.obolibrary.org/obo/GO_0042627) (chylomicron), [GO:0007586](http://purl.obolibrary.org/obo/GO_0007586) (digestion), [GO:0006497](http://purl.obolibrary.org/obo/GO_0006497) (protein lipidation), [GO:0031307](http://purl.obolibrary.org/obo/GO_0031307) (integral component of mitochondrial outer membrane), [GO:0070072](http://purl.obolibrary.org/obo/GO_0070072) (vacuolar proton-transporting V-type ATPase complex assembly), [GO:0047086](http://purl.obolibrary.org/obo/GO_0047086) (ketosteroid monooxygenase activity), [GO:0010989](http://purl.obolibrary.org/obo/GO_0010989) (negative regulation of low-density lipoprotein particle clearance), [GO:0010867](http://purl.obolibrary.org/obo/GO_0010867) (positive regulation of triglyceride biosynthetic process), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0019432](http://purl.obolibrary.org/obo/GO_0019432) (triglyceride biosynthetic process), [GO:0010987](http://purl.obolibrary.org/obo/GO_0010987) (negative regulation of high-density lipoprotein particle clearance), [GO:0019433](http://purl.obolibrary.org/obo/GO_0019433) (triglyceride catabolic process), [GO:0010744](http://purl.obolibrary.org/obo/GO_0010744) (positive regulation of macrophage derived foam cell differentiation), [GO:0030573](http://purl.obolibrary.org/obo/GO_0030573) (bile acid catabolic process), [GO:0061370](http://purl.obolibrary.org/obo/GO_0061370) (testosterone biosynthetic process), [GO:0030335](http://purl.obolibrary.org/obo/GO_0030335) (positive regulation of cell migration), [GO:0042756](http://purl.obolibrary.org/obo/GO_0042756) (drinking behavior), [GO:0005134](http://purl.obolibrary.org/obo/GO_0005134) (interleukin-2 receptor binding), [GO:0005496](http://purl.obolibrary.org/obo/GO_0005496) (steroid binding), [GO:0042632](http://purl.obolibrary.org/obo/GO_0042632) (cholesterol homeostasis), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0043602](http://purl.obolibrary.org/obo/GO_0043602) (nitrate catabolic process), [GO:0042755](http://purl.obolibrary.org/obo/GO_0042755) (eating behavior), [GO:0048188](http://purl.obolibrary.org/obo/GO_0048188) (Set1C/COMPASS complex), [GO:0007548](http://purl.obolibrary.org/obo/GO_0007548) (sex differentiation), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0060192](http://purl.obolibrary.org/obo/GO_0060192) (negative regulation of lipase activity), [GO:0032981](http://purl.obolibrary.org/obo/GO_0032981) (mitochondrial respiratory chain complex I assembly), [GO:0032866](http://purl.obolibrary.org/obo/GO_0032866) (D-xylose:NADP reductase activity), [GO:0017127](http://purl.obolibrary.org/obo/GO_0017127) (cholesterol transporter activity), [GO:0030324](http://purl.obolibrary.org/obo/GO_0030324) (lung development), [GO:0061024](http://purl.obolibrary.org/obo/GO_0061024) (membrane organization), [GO:0042406](http://purl.obolibrary.org/obo/GO_0042406) (extrinsic component of endoplasmic reticulum membrane), [GO:0042407](http://purl.obolibrary.org/obo/GO_0042407) (cristae formation), [GO:0008654](http://purl.obolibrary.org/obo/GO_0008654) (phospholipid biosynthetic process), [GO:0009743](http://purl.obolibrary.org/obo/GO_0009743) (response to carbohydrate), [GO:0042760](http://purl.obolibrary.org/obo/GO_0042760) (very long-chain fatty acid catabolic process), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0007567](http://purl.obolibrary.org/obo/GO_0007567) (parturition), [GO:0031528](http://purl.obolibrary.org/obo/GO_0031528) (microvillus membrane), [GO:0031526](http://purl.obolibrary.org/obo/GO_0031526) (brush border membrane), [GO:0030317](http://purl.obolibrary.org/obo/GO_0030317) (flagellated sperm motility), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0033700](http://purl.obolibrary.org/obo/GO_0033700) (phospholipid efflux), [GO:0052689](http://purl.obolibrary.org/obo/GO_0052689) (carboxylic ester hydrolase activity), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), [GO:0033540](http://purl.obolibrary.org/obo/GO_0033540) (fatty acid beta-oxidation using acyl-CoA oxidase), [GO:1905146](http://purl.obolibrary.org/obo/GO_1905146) (lysosomal protein catabolic process), [GO:0009791](http://purl.obolibrary.org/obo/GO_0009791) (post-embryonic development), [GO:0009437](http://purl.obolibrary.org/obo/GO_0009437) (carnitine metabolic process), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0033539](http://purl.obolibrary.org/obo/GO_0033539) (fatty acid beta-oxidation using acyl-CoA dehydrogenase), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0018393](http://purl.obolibrary.org/obo/GO_0018393) (internal peptidyl-lysine acetylation), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0043473](http://purl.obolibrary.org/obo/GO_0043473) (pigmentation), [GO:0010897](http://purl.obolibrary.org/obo/GO_0010897) (negative regulation of triglyceride catabolic process), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:0010898](http://purl.obolibrary.org/obo/GO_0010898) (positive regulation of triglyceride catabolic process), [GO:0071813](http://purl.obolibrary.org/obo/GO_0071813) (lipoprotein particle binding), [GO:0090107](http://purl.obolibrary.org/obo/GO_0090107) (regulation of high-density lipoprotein particle assembly), [GO:0090346](http://purl.obolibrary.org/obo/GO_0090346) (cellular organofluorine metabolic process), [GO:0009566](http://purl.obolibrary.org/obo/GO_0009566) (fertilization), [GO:0047953](http://purl.obolibrary.org/obo/GO_0047953) (glycerol 2-dehydrogenase (NADP+) activity), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0043236](http://purl.obolibrary.org/obo/GO_0043236) (laminin binding), [GO:0045777](http://purl.obolibrary.org/obo/GO_0045777) (positive regulation of blood pressure), [GO:0045540](http://purl.obolibrary.org/obo/GO_0045540) (regulation of cholesterol biosynthetic process), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0031102](http://purl.obolibrary.org/obo/GO_0031102) (neuron projection regeneration), [GO:0034614](http://purl.obolibrary.org/obo/GO_0034614) (cellular response to reactive oxygen species), [GO:0031224](http://purl.obolibrary.org/obo/GO_0031224) (intrinsic component of membrane), [GO:0030137](http://purl.obolibrary.org/obo/GO_0030137) (COPI-coated vesicle), [GO:0031225](http://purl.obolibrary.org/obo/GO_0031225) (anchored component of membrane), [GO:0008320](http://purl.obolibrary.org/obo/GO_0008320) (protein transmembrane transporter activity), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0043123](http://purl.obolibrary.org/obo/GO_0043123) (positive regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0008202](http://purl.obolibrary.org/obo/GO_0008202) (steroid metabolic process), [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding), [GO:0005178](http://purl.obolibrary.org/obo/GO_0005178) (integrin binding), [GO:0045542](http://purl.obolibrary.org/obo/GO_0045542) (positive regulation of cholesterol biosynthetic process), [GO:0042157](http://purl.obolibrary.org/obo/GO_0042157) (lipoprotein metabolic process), [GO:0042158](http://purl.obolibrary.org/obo/GO_0042158) (lipoprotein biosynthetic process), [GO:0008207](http://purl.obolibrary.org/obo/GO_0008207) (C21-steroid hormone metabolic process), [GO:0042159](http://purl.obolibrary.org/obo/GO_0042159) (lipoprotein catabolic process), [GO:0047726](http://purl.obolibrary.org/obo/GO_0047726) (iron-cytochrome-c reductase activity), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0010519](http://purl.obolibrary.org/obo/GO_0010519) (negative regulation of phospholipase activity), [GO:0016192](http://purl.obolibrary.org/obo/GO_0016192) (vesicle-mediated transport), [GO:0010518](http://purl.obolibrary.org/obo/GO_0010518) (positive regulation of phospholipase activity), [GO:0045550](http://purl.obolibrary.org/obo/GO_0045550) (geranylgeranyl reductase activity), [GO:0030121](http://purl.obolibrary.org/obo/GO_0030121) (AP-1 adaptor complex), [GO:0010874](http://purl.obolibrary.org/obo/GO_0010874) (regulation of cholesterol efflux), [GO:0055102](http://purl.obolibrary.org/obo/GO_0055102) (lipase inhibitor activity), [GO:0031210](http://purl.obolibrary.org/obo/GO_0031210) (phosphatidylcholine binding), [GO:0030122](http://purl.obolibrary.org/obo/GO_0030122) (AP-2 adaptor complex), [GO:0090319](http://purl.obolibrary.org/obo/GO_0090319) (positive regulation of chylomicron remodeling), [GO:0070988](http://purl.obolibrary.org/obo/GO_0070988) (demethylation), [GO:0010873](http://purl.obolibrary.org/obo/GO_0010873) (positive regulation of cholesterol esterification), [GO:0030127](http://purl.obolibrary.org/obo/GO_0030127) (COPII vesicle coat), [GO:0031214](http://purl.obolibrary.org/obo/GO_0031214) (biomineral tissue development), [GO:0071949](http://purl.obolibrary.org/obo/GO_0071949) (FAD binding), [GO:0004090](http://purl.obolibrary.org/obo/GO_0004090) (carbonyl reductase (NADPH) activity), [GO:0090324](http://purl.obolibrary.org/obo/GO_0090324) (negative regulation of oxidative phosphorylation), [GO:0010890](http://purl.obolibrary.org/obo/GO_0010890) (positive regulation of sequestering of triglyceride), [GO:0070859](http://purl.obolibrary.org/obo/GO_0070859) (positive regulation of bile acid biosynthetic process), [GO:0090321](http://purl.obolibrary.org/obo/GO_0090321) (positive regulation of chylomicron remnant clearance), [GO:0004095](http://purl.obolibrary.org/obo/GO_0004095) (carnitine O-palmitoyltransferase activity), [GO:0008211](http://purl.obolibrary.org/obo/GO_0008211) (glucocorticoid metabolic process), [GO:0007007](http://purl.obolibrary.org/obo/GO_0007007) (inner mitochondrial membrane organization), [GO:0009306](http://purl.obolibrary.org/obo/GO_0009306) (protein secretion), [GO:0008217](http://purl.obolibrary.org/obo/GO_0008217) (regulation of blood pressure), [GO:0046889](http://purl.obolibrary.org/obo/GO_0046889) (positive regulation of lipid biosynthetic process), [GO:0007006](http://purl.obolibrary.org/obo/GO_0007006) (mitochondrial membrane organization), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0008209](http://purl.obolibrary.org/obo/GO_0008209) (androgen metabolic process), [GO:0010886](http://purl.obolibrary.org/obo/GO_0010886) (positive regulation of cholesterol storage), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0070971](http://purl.obolibrary.org/obo/GO_0070971) (endoplasmic reticulum exit site), [GO:0001816](http://purl.obolibrary.org/obo/GO_0001816) (cytokine production), [GO:0001938](http://purl.obolibrary.org/obo/GO_0001938) (positive regulation of endothelial cell proliferation), [GO:0017038](http://purl.obolibrary.org/obo/GO_0017038) (protein import), [GO:0010884](http://purl.obolibrary.org/obo/GO_0010884) (positive regulation of lipid storage), [GO:0071944](http://purl.obolibrary.org/obo/GO_0071944) (cell periphery), [GO:0032374](http://purl.obolibrary.org/obo/GO_0032374) (regulation of cholesterol transport), [GO:0008022](http://purl.obolibrary.org/obo/GO_0008022) (protein C-terminus binding), [GO:0042574](http://purl.obolibrary.org/obo/GO_0042574) (retinal metabolic process), [GO:0001991](http://purl.obolibrary.org/obo/GO_0001991) (regulation of systemic arterial blood pressure by circulatory renin-angiotensin), [GO:0045723](http://purl.obolibrary.org/obo/GO_0045723) (positive regulation of fatty acid biosynthetic process), [GO:0015909](http://purl.obolibrary.org/obo/GO_0015909) (long-chain fatty acid transport), [GO:0001503](http://purl.obolibrary.org/obo/GO_0001503) (ossification), [GO:0051287](http://purl.obolibrary.org/obo/GO_0051287) (NAD binding), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0035754](http://purl.obolibrary.org/obo/GO_0035754) (B cell chemotaxis), [GO:0035634](http://purl.obolibrary.org/obo/GO_0035634) (response to stilbenoid), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0032000](http://purl.obolibrary.org/obo/GO_0032000) (positive regulation of fatty acid beta-oxidation), [GO:0030061](http://purl.obolibrary.org/obo/GO_0030061) (mitochondrial crista), [GO:0008396](http://purl.obolibrary.org/obo/GO_0008396) (oxysterol 7-alpha-hydroxylase activity), [GO:0008395](http://purl.obolibrary.org/obo/GO_0008395) (steroid hydroxylase activity), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0008035](http://purl.obolibrary.org/obo/GO_0008035) (high-density lipoprotein particle binding), [GO:0043434](http://purl.obolibrary.org/obo/GO_0043434) (response to peptide hormone), [GO:1990698](http://purl.obolibrary.org/obo/GO_1990698) (palmitoleoyltransferase activity), [GO:0019395](http://purl.obolibrary.org/obo/GO_0019395) (fatty acid oxidation), [GO:0001758](http://purl.obolibrary.org/obo/GO_0001758) (retinal dehydrogenase activity), [GO:0030176](http://purl.obolibrary.org/obo/GO_0030176) (integral component of endoplasmic reticulum membrane), [GO:0015914](http://purl.obolibrary.org/obo/GO_0015914) (phospholipid transport), [GO:0030299](http://purl.obolibrary.org/obo/GO_0030299) (intestinal cholesterol absorption), [GO:0015910](http://purl.obolibrary.org/obo/GO_0015910) (peroxisomal long-chain fatty acid import), [GO:0010466](http://purl.obolibrary.org/obo/GO_0010466) (negative regulation of peptidase activity), [GO:0034651](http://purl.obolibrary.org/obo/GO_0034651) (cortisol biosynthetic process), [GO:0034650](http://purl.obolibrary.org/obo/GO_0034650) (cortisol metabolic process), [GO:0007031](http://purl.obolibrary.org/obo/GO_0007031) (peroxisome organization), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0007035](http://purl.obolibrary.org/obo/GO_0007035) (vacuolar acidification), [GO:0001960](http://purl.obolibrary.org/obo/GO_0001960) (negative regulation of cytokine-mediated signaling pathway), [GO:0043691](http://purl.obolibrary.org/obo/GO_0043691) (reverse cholesterol transport), [GO:0019388](http://purl.obolibrary.org/obo/GO_0019388) (galactose catabolic process), [GO:0032342](http://purl.obolibrary.org/obo/GO_0032342) (aldosterone biosynthetic process), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0030169](http://purl.obolibrary.org/obo/GO_0030169) (low-density lipoprotein particle binding), [GO:0006071](http://purl.obolibrary.org/obo/GO_0006071) (glycerol metabolic process), [GO:0007160](http://purl.obolibrary.org/obo/GO_0007160) (cell-matrix adhesion), [GO:0008374](http://purl.obolibrary.org/obo/GO_0008374) (O-acyltransferase activity), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0033791](http://purl.obolibrary.org/obo/GO_0033791) (3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity), [GO:0007042](http://purl.obolibrary.org/obo/GO_0007042) (lysosomal lumen acidification), [GO:0051082](http://purl.obolibrary.org/obo/GO_0051082) (unfolded protein binding), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0012506](http://purl.obolibrary.org/obo/GO_0012506) (vesicle membrane), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0045880](http://purl.obolibrary.org/obo/GO_0045880) (positive regulation of smoothened signaling pathway), [GO:0012507](http://purl.obolibrary.org/obo/GO_0012507) (ER to Golgi transport vesicle membrane), [GO:0035965](http://purl.obolibrary.org/obo/GO_0035965) (cardiolipin acyl-chain remodeling), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0002828](http://purl.obolibrary.org/obo/GO_0002828) (regulation of type 2 immune response), [GO:0032332](http://purl.obolibrary.org/obo/GO_0032332) (positive regulation of chondrocyte differentiation), [GO:0009395](http://purl.obolibrary.org/obo/GO_0009395) (phospholipid catabolic process), [GO:0046337](http://purl.obolibrary.org/obo/GO_0046337) (phosphatidylethanolamine metabolic process), [GO:0047787](http://purl.obolibrary.org/obo/GO_0047787) (delta4-3-oxosteroid 5beta-reductase activity), [GO:0046461](http://purl.obolibrary.org/obo/GO_0046461) (neutral lipid catabolic process), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0005902](http://purl.obolibrary.org/obo/GO_0005902) (microvillus), [GO:0070325](http://purl.obolibrary.org/obo/GO_0070325) (lipoprotein particle receptor binding), [GO:0032048](http://purl.obolibrary.org/obo/GO_0032048) (cardiolipin metabolic process), [GO:0003729](http://purl.obolibrary.org/obo/GO_0003729) (mRNA binding), [GO:0070328](http://purl.obolibrary.org/obo/GO_0070328) (triglyceride homeostasis), [GO:0032049](http://purl.obolibrary.org/obo/GO_0032049) (cardiolipin biosynthetic process), [GO:0070326](http://purl.obolibrary.org/obo/GO_0070326) (very-low-density lipoprotein particle receptor binding), [GO:0031073](http://purl.obolibrary.org/obo/GO_0031073) (cholesterol 26-hydroxylase activity), [GO:0090181](http://purl.obolibrary.org/obo/GO_0090181) (regulation of cholesterol metabolic process), [GO:0046471](http://purl.obolibrary.org/obo/GO_0046471) (phosphatidylglycerol metabolic process), [GO:0048771](http://purl.obolibrary.org/obo/GO_0048771) (tissue remodeling), [GO:0001676](http://purl.obolibrary.org/obo/GO_0001676) (long-chain fatty acid metabolic process), [GO:0003854](http://purl.obolibrary.org/obo/GO_0003854) (3-beta-hydroxy-delta5-steroid dehydrogenase activity), [GO:0046470](http://purl.obolibrary.org/obo/GO_0046470) (phosphatidylcholine metabolic process), [GO:2000404](http://purl.obolibrary.org/obo/GO_2000404) (regulation of T cell migration), [GO:0046475](http://purl.obolibrary.org/obo/GO_0046475) (glycerophospholipid catabolic process), [GO:0001558](http://purl.obolibrary.org/obo/GO_0001558) (regulation of cell growth), [GO:0046473](http://purl.obolibrary.org/obo/GO_0046473) (phosphatidic acid metabolic process), [GO:0047442](http://purl.obolibrary.org/obo/GO_0047442) (17-alpha-hydroxyprogesterone aldolase activity), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0055075](http://purl.obolibrary.org/obo/GO_0055075) (potassium ion homeostasis), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0055078](http://purl.obolibrary.org/obo/GO_0055078) (sodium ion homeostasis), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0047568](http://purl.obolibrary.org/obo/GO_0047568) (3-oxo-5-beta-steroid 4-dehydrogenase activity), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0008047](http://purl.obolibrary.org/obo/GO_0008047) (enzyme activator activity), [GO:0090031](http://purl.obolibrary.org/obo/GO_0090031) (positive regulation of steroid hormone biosynthetic process), [GO:0001650](http://purl.obolibrary.org/obo/GO_0001650) (fibrillar center), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0071799](http://purl.obolibrary.org/obo/GO_0071799) (cellular response to prostaglandin D stimulus), [GO:0033116](http://purl.obolibrary.org/obo/GO_0033116) (endoplasmic reticulum-Golgi intermediate compartment membrane), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0035410](http://purl.obolibrary.org/obo/GO_0035410) (dihydrotestosterone 17-beta-dehydrogenase activity), [GO:0055088](http://purl.obolibrary.org/obo/GO_0055088) (lipid homeostasis), [GO:0000329](http://purl.obolibrary.org/obo/GO_0000329) (fungal-type vacuole membrane), [GO:0001540](http://purl.obolibrary.org/obo/GO_0001540) (amyloid-beta binding), [GO:0020037](http://purl.obolibrary.org/obo/GO_0020037) (heme binding), [GO:0003958](http://purl.obolibrary.org/obo/GO_0003958) (NADPH-hemoprotein reductase activity), [GO:0034435](http://purl.obolibrary.org/obo/GO_0034435) (cholesterol esterification), [GO:0004806](http://purl.obolibrary.org/obo/GO_0004806) (triglyceride lipase activity), [GO:0033344](http://purl.obolibrary.org/obo/GO_0033344) (cholesterol efflux), [GO:0032375](http://purl.obolibrary.org/obo/GO_0032375) (negative regulation of cholesterol transport), [GO:0034394](http://purl.obolibrary.org/obo/GO_0034394) (protein localization to cell surface), [GO:0010181](http://purl.obolibrary.org/obo/GO_0010181) (FMN binding), [GO:0044597](http://purl.obolibrary.org/obo/GO_0044597) (daunorubicin metabolic process), [GO:0044233](http://purl.obolibrary.org/obo/GO_0044233) (ER-mitochondrion membrane contact site), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0044598](http://purl.obolibrary.org/obo/GO_0044598) (doxorubicin metabolic process), [GO:0046658](http://purl.obolibrary.org/obo/GO_0046658) (anchored component of plasma membrane), [GO:0004620](http://purl.obolibrary.org/obo/GO_0004620) (phospholipase activity), [GO:0004857](http://purl.obolibrary.org/obo/GO_0004857) (enzyme inhibitor activity), [GO:0043154](http://purl.obolibrary.org/obo/GO_0043154) (negative regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0043395](http://purl.obolibrary.org/obo/GO_0043395) (heparan sulfate proteoglycan binding), [GO:0043274](http://purl.obolibrary.org/obo/GO_0043274) (phospholipase binding), [GO:0004859](http://purl.obolibrary.org/obo/GO_0004859) (phospholipase inhibitor activity), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0035478](http://purl.obolibrary.org/obo/GO_0035478) (chylomicron binding), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0035473](http://purl.obolibrary.org/obo/GO_0035473) (lipase binding), [GO:0034383](http://purl.obolibrary.org/obo/GO_0034383) (low-density lipoprotein particle clearance), [GO:0034382](http://purl.obolibrary.org/obo/GO_0034382) (chylomicron remnant clearance), [GO:0034380](http://purl.obolibrary.org/obo/GO_0034380) (high-density lipoprotein particle assembly), [GO:0034384](http://purl.obolibrary.org/obo/GO_0034384) (high-density lipoprotein particle clearance), [GO:0048844](http://purl.obolibrary.org/obo/GO_0048844) (artery morphogenesis), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0003420](http://purl.obolibrary.org/obo/GO_0003420) (regulation of growth plate cartilage chondrocyte proliferation), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0000266](http://purl.obolibrary.org/obo/GO_0000266) (mitochondrial fission), [GO:0004623](http://purl.obolibrary.org/obo/GO_0004623) (phospholipase A2 activity), [GO:0004622](http://purl.obolibrary.org/obo/GO_0004622) (lysophospholipase activity), [GO:0004745](http://purl.obolibrary.org/obo/GO_0004745) (retinol dehydrogenase activity), [GO:0004508](http://purl.obolibrary.org/obo/GO_0004508) (steroid 17-alpha-monooxygenase activity), [GO:0004507](http://purl.obolibrary.org/obo/GO_0004507) (steroid 11-beta-monooxygenase activity), [GO:0006805](http://purl.obolibrary.org/obo/GO_0006805) (xenobiotic metabolic process), [GO:0034379](http://purl.obolibrary.org/obo/GO_0034379) (very-low-density lipoprotein particle assembly), [GO:0004509](http://purl.obolibrary.org/obo/GO_0004509) (steroid 21-monooxygenase activity), [GO:0050801](http://purl.obolibrary.org/obo/GO_0050801) (ion homeostasis), [GO:0034377](http://purl.obolibrary.org/obo/GO_0034377) (plasma lipoprotein particle assembly), [GO:0034372](http://purl.obolibrary.org/obo/GO_0034372) (very-low-density lipoprotein particle remodeling), [GO:0034371](http://purl.obolibrary.org/obo/GO_0034371) (chylomicron remodeling), [GO:0034370](http://purl.obolibrary.org/obo/GO_0034370) (triglyceride-rich lipoprotein particle remodeling), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0060740](http://purl.obolibrary.org/obo/GO_0060740) (prostate gland epithelium morphogenesis), [GO:0034375](http://purl.obolibrary.org/obo/GO_0034375) (high-density lipoprotein particle remodeling), [GO:0016705](http://purl.obolibrary.org/obo/GO_0016705) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen), [GO:0034374](http://purl.obolibrary.org/obo/GO_0034374) (low-density lipoprotein particle remodeling), [GO:0009055](http://purl.obolibrary.org/obo/GO_0009055) (electron transfer activity), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:0044255](http://purl.obolibrary.org/obo/GO_0044255) (cellular lipid metabolic process), [GO:0048738](http://purl.obolibrary.org/obo/GO_0048738) (cardiac muscle tissue development), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0046320](http://purl.obolibrary.org/obo/GO_0046320) (regulation of fatty acid oxidation), [GO:0034366](http://purl.obolibrary.org/obo/GO_0034366) (spherical high-density lipoprotein particle), [GO:0050810](http://purl.obolibrary.org/obo/GO_0050810) (regulation of steroid biosynthetic process), [GO:0035457](http://purl.obolibrary.org/obo/GO_0035457) (cellular response to interferon-alpha), [GO:0034361](http://purl.obolibrary.org/obo/GO_0034361) (very-low-density lipoprotein particle), [GO:0034364](http://purl.obolibrary.org/obo/GO_0034364) (high-density lipoprotein particle), [GO:0034363](http://purl.obolibrary.org/obo/GO_0034363) (intermediate-density lipoprotein particle), [GO:0034362](http://purl.obolibrary.org/obo/GO_0034362) (low-density lipoprotein particle), [GO:0046688](http://purl.obolibrary.org/obo/GO_0046688) (response to copper ion), [GO:0003400](http://purl.obolibrary.org/obo/GO_0003400) (regulation of COPII vesicle coating), [GO:0003995](http://purl.obolibrary.org/obo/GO_0003995) (acyl-CoA dehydrogenase activity), [GO:1990871](http://purl.obolibrary.org/obo/GO_1990871) (Vma12-Vma22 assembly complex), [GO:0003997](http://purl.obolibrary.org/obo/GO_0003997) (acyl-CoA oxidase activity), [GO:0001579](http://purl.obolibrary.org/obo/GO_0001579) (medium-chain fatty acid transport), [GO:0048873](http://purl.obolibrary.org/obo/GO_0048873) (homeostasis of number of cells within a tissue), [GO:0004607](http://purl.obolibrary.org/obo/GO_0004607) (phosphatidylcholine-sterol O-acyltransferase activity), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0047783](http://purl.obolibrary.org/obo/GO_0047783) (corticosterone 18-monooxygenase activity), [GO:0046210](http://purl.obolibrary.org/obo/GO_0046210) (nitric oxide catabolic process), [GO:0034599](http://purl.obolibrary.org/obo/GO_0034599) (cellular response to oxidative stress), [GO:0033147](http://purl.obolibrary.org/obo/GO_0033147) (negative regulation of intracellular estrogen receptor signaling pathway), [GO:0070653](http://purl.obolibrary.org/obo/GO_0070653) (high-density lipoprotein particle receptor binding), [GO:0050821](http://purl.obolibrary.org/obo/GO_0050821) (protein stabilization), [GO:0034359](http://purl.obolibrary.org/obo/GO_0034359) (mature chylomicron), [GO:2000224](http://purl.obolibrary.org/obo/GO_2000224) (regulation of testosterone biosynthetic process), 

**Class expressions from DL-Learner:**

- Thing 59.38%
- [GO:0034358](http://purl.obolibrary.org/obo/GO_0034358) (plasma lipoprotein particle) 51.16%
- [GO:0034385](http://purl.obolibrary.org/obo/GO_0034385) (triglyceride-rich plasma lipoprotein particle) 50.47%
- [GO:0031968](http://purl.obolibrary.org/obo/GO_0031968) (organelle outer membrane) 50.47%
- [GO:0031966](http://purl.obolibrary.org/obo/GO_0031966) (mitochondrial membrane) 50.47%
- [GO:0019867](http://purl.obolibrary.org/obo/GO_0019867) (outer membrane) 50.47%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 50.23%
- [GO:0042627](http://purl.obolibrary.org/obo/GO_0042627) (chylomicron) 50.23%
- [GO:0034366](http://purl.obolibrary.org/obo/GO_0034366) (spherical high-density lipoprotein particle) 50.23%
- [GO:0034364](http://purl.obolibrary.org/obo/GO_0034364) (high-density lipoprotein particle) 50.23%
- [GO:0034363](http://purl.obolibrary.org/obo/GO_0034363) (intermediate-density lipoprotein particle) 50.23%
- [GO:0034362](http://purl.obolibrary.org/obo/GO_0034362) (low-density lipoprotein particle) 50.23%
- [GO:0034361](http://purl.obolibrary.org/obo/GO_0034361) (very-low-density lipoprotein particle) 50.23%
- [GO:0034359](http://purl.obolibrary.org/obo/GO_0034359) (mature chylomicron) 50.23%
- [GO:0033116](http://purl.obolibrary.org/obo/GO_0033116) (endoplasmic reticulum-Golgi intermediate compartment membrane) 50.23%


